Tuesday , January 26 2021

New treatment "Breakthrough" for children with peanut allergy, research

The study, funded by Aimmune Therapeutics, included 551 participants, all of whom were allergic to peanuts. Participants ranged in age from 4 to 55 years, although most of them were children aged 4 to 17 years. The researchers gave a quarter of the placebo participants, while three quarters received oral doses of a small amount of peanut protein powder, starting at half a milligram per day; the amount increased gradually until a maintenance dose of 300 milligrams was reached, which is equivalent to one peanut per day.

Source link